Ranjbar Jacob, Njoroge Wanjiku, Gibbins Jonathan M, Roach Paul, Yang Ying, Harper Alan G S
School of Medicine, Keele University, Keele ST5 5BG, UK.
School of Pharmacy & Bioengineering, Keele University, Keele ST5 5BG, UK.
Gels. 2023 Jun 10;9(6):477. doi: 10.3390/gels9060477.
Current in vitro thrombosis models utilise simplistic 2D surfaces coated with purified components of the subendothelial matrix. The lack of a realistic humanised model has led to greater study of thrombus formation in in vivo tests in animals. Here we aimed to develop 3D hydrogel-based replicas of the medial and adventitial layers of the human artery to produce a surface that can optimally support thrombus formation under physiological flow conditions. These tissue-engineered medial- (TEML) and adventitial-layer (TEAL) hydrogels were developed by culturing human coronary artery smooth muscle cells and human aortic adventitial fibroblasts within collagen hydrogels, both individually and in co-culture. Platelet aggregation upon these hydrogels was studied using a custom-made parallel flow chamber. When cultured in the presence of ascorbic acid, the medial-layer hydrogels were able to produce sufficient neo-collagen to support effective platelet aggregation under arterial flow conditions. Both TEML and TEAL hydrogels possessed measurable tissue factor activity and could trigger coagulation of platelet-poor plasma in a factor VII-dependent manner. Biomimetic hydrogel replicas of the subendothelial layers of the human artery are effective substrates for a humanised in vitro thrombosis model that could reduce animal experimentation by replacing current in vivo models.
当前的体外血栓形成模型使用涂有内皮下基质纯化成分的简单二维表面。缺乏逼真的人源化模型导致对动物体内血栓形成的研究增多。在此,我们旨在开发基于三维水凝胶的人体动脉中层和外膜层复制品,以制造一种在生理流动条件下能最佳支持血栓形成的表面。这些组织工程化中层(TEML)和外膜层(TEAL)水凝胶是通过在胶原水凝胶中单独或共培养人冠状动脉平滑肌细胞和人主动脉外膜成纤维细胞而开发的。使用定制的平行流室研究血小板在这些水凝胶上的聚集情况。当在抗坏血酸存在下培养时,中层水凝胶能够产生足够的新胶原蛋白,以支持动脉血流条件下有效的血小板聚集。TEML和TEAL水凝胶均具有可测量的组织因子活性,并能以因子VII依赖的方式触发贫血小板血浆的凝血。人体动脉内皮下层的仿生水凝胶复制品是一种有效的人源化体外血栓形成模型的底物,可通过替代当前的体内模型减少动物实验。